FR2685333B1 - Nouveau peptide notamment pour la realisation de conjugues immunogenes anti-lhrh, vaccins les incorporant et ensemble de vaccination y relatif. - Google Patents

Nouveau peptide notamment pour la realisation de conjugues immunogenes anti-lhrh, vaccins les incorporant et ensemble de vaccination y relatif.

Info

Publication number
FR2685333B1
FR2685333B1 FR9115289A FR9115289A FR2685333B1 FR 2685333 B1 FR2685333 B1 FR 2685333B1 FR 9115289 A FR9115289 A FR 9115289A FR 9115289 A FR9115289 A FR 9115289A FR 2685333 B1 FR2685333 B1 FR 2685333B1
Authority
FR
France
Prior art keywords
lhrh
vaccination
realization
new peptide
immunogenic conjugates
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
FR9115289A
Other languages
English (en)
Other versions
FR2685333A1 (fr
Inventor
Raymond Dufour
Claude Roulet
Claire Chouvet
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim Animal Health France SAS
Original Assignee
Rhone Merieux SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR9115289A priority Critical patent/FR2685333B1/fr
Application filed by Rhone Merieux SA filed Critical Rhone Merieux SA
Priority to PCT/FR1992/000176 priority patent/WO1992015330A1/fr
Priority to AT92400496T priority patent/ATE194625T1/de
Priority to UA93004193A priority patent/UA40570C2/uk
Priority to PL29662392A priority patent/PL296623A1/xx
Priority to PT92400496T priority patent/PT501882E/pt
Priority to DE69231232T priority patent/DE69231232T2/de
Priority to JP50689392A priority patent/JP3177246B2/ja
Priority to CA002081660A priority patent/CA2081660C/fr
Priority to HU9203419A priority patent/HU214453B/hu
Priority to SK3280-92A priority patent/SK282056B6/sk
Priority to ES92400496T priority patent/ES2149166T3/es
Priority to EP92400496A priority patent/EP0501882B1/fr
Priority to DK92400496T priority patent/DK0501882T3/da
Priority to KR1019920702707A priority patent/KR100257214B1/ko
Priority to IE064892A priority patent/IE920648A1/en
Priority to TW081101687A priority patent/TW221674B/zh
Priority to AU25237/92A priority patent/AU640603B3/en
Priority to CZ19923280A priority patent/CZ287775B6/cs
Priority to MX9207129A priority patent/MX9207129A/es
Publication of FR2685333A1 publication Critical patent/FR2685333A1/fr
Priority to US08/343,883 priority patent/US5573767A/en
Publication of FR2685333B1 publication Critical patent/FR2685333B1/fr
Application granted granted Critical
Priority to GR20000402199T priority patent/GR3034509T3/el
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/09—Luteinising hormone-releasing hormone [LHRH], i.e. Gonadotropin-releasing hormone [GnRH]; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0006—Contraceptive vaccins; Vaccines against sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/23—Luteinising hormone-releasing hormone [LHRH]; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55577—Saponins; Quil A; QS21; ISCOMS
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6081—Albumin; Keyhole limpet haemocyanin [KLH]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Mycology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
FR9115289A 1991-03-01 1991-12-10 Nouveau peptide notamment pour la realisation de conjugues immunogenes anti-lhrh, vaccins les incorporant et ensemble de vaccination y relatif. Expired - Lifetime FR2685333B1 (fr)

Priority Applications (22)

Application Number Priority Date Filing Date Title
FR9115289A FR2685333B1 (fr) 1991-12-10 1991-12-10 Nouveau peptide notamment pour la realisation de conjugues immunogenes anti-lhrh, vaccins les incorporant et ensemble de vaccination y relatif.
KR1019920702707A KR100257214B1 (ko) 1991-03-01 1992-02-26 거세되지 않은 수컷가축의 고기의 관능적 품질을 개선하기 위한 방법
AT92400496T ATE194625T1 (de) 1991-03-01 1992-02-26 Verfahren zur immunoneutralisierung von nichtkastrierten männlichen haustieren gegen lmrh und peptide dafür
DK92400496T DK0501882T3 (da) 1991-03-01 1992-02-26 Fremgangsmåde til anti-LHRH immunoneutralisering af ikke-kastrerede husdyrhanner og peptider dertil
PT92400496T PT501882E (pt) 1991-03-01 1992-02-26 Processo de imunoneutralizacao anti-lhrm de animais domesticos machos nao castrados e peptido para esse fim
DE69231232T DE69231232T2 (de) 1991-03-01 1992-02-26 Verfahren zur Immunoneutralisierung von nichtkastrierten männlichen Haustieren gegen LMRH und Peptide dafür
JP50689392A JP3177246B2 (ja) 1991-03-01 1992-02-26 未去勢のオスの家畜に対する抗ｌｈｒｈ免疫方法と、そのためのペプチド
CA002081660A CA2081660C (fr) 1991-03-01 1992-02-26 Methode pour ameliorer les qualites organoleptiques de la viande de verrats et vaccin utilise a cet effet
HU9203419A HU214453B (hu) 1991-03-01 1992-02-26 Eljárás húsok organoleptikus minőségének javítására
SK3280-92A SK282056B6 (sk) 1991-03-01 1992-02-26 Spôsob zlepšenia organoleptických vlastností mäsa nevykastrovaných samcov domácich zvierat
ES92400496T ES2149166T3 (es) 1991-03-01 1992-02-26 Procedimiento de inmunoneutralizacion anti-lhrm de los animales domesticos machos no castrados y peptido para su realizacion.
EP92400496A EP0501882B1 (fr) 1991-03-01 1992-02-26 Procédé d'immunoneutralisation anti-LHRM des animaux domestiques mâles non castrés et peptide pour cela
PCT/FR1992/000176 WO1992015330A1 (fr) 1991-03-01 1992-02-26 Procede d'immunoneutralisation anti-lhrh des animaux domestiques males non castres et peptide pour cela
UA93004193A UA40570C2 (uk) 1991-03-01 1992-02-26 Спосіб виробництва м'яса свиней, великої та малої рогатої худоби, що має поліпшені органолептичні властивості, і набір для анти-лгрг вакцинації
PL29662392A PL296623A1 (en) 1991-03-01 1992-02-26 Method of improving organoleptic properties of male slaughter animal meat
IE064892A IE920648A1 (en) 1991-03-01 1992-02-28 A method for improving the organoleptic qualities of meat
TW081101687A TW221674B (fr) 1991-03-01 1992-03-05
AU25237/92A AU640603B3 (en) 1991-12-10 1992-09-18 Method
CZ19923280A CZ287775B6 (cs) 1991-03-01 1992-10-30 Způsob zlepšení organoleptických vlastností masa nevykastrovaných samců domácích zvířat
MX9207129A MX9207129A (es) 1991-12-10 1992-12-09 Metodo para mejorar las cualidades organolepticas de la carne de animales domesticos sin castrar, vacunas que son utilizables en este metodo, nuevo peptido, en particular, para producir esas vacunas, y estuche de vacunacion relacionado con ello.
US08/343,883 US5573767A (en) 1991-03-01 1994-11-17 Method for improving the organoleptic qualities of the meat from uncastrated male domestic animals, vaccines which are usable in this method, new peptide, in particular for producing these vaccines and vaccination kit relating thereto
GR20000402199T GR3034509T3 (en) 1991-03-01 2000-09-28 Method of anti LHRH immunoneutralization of non-castrated male animals and peptide therefore.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9115289A FR2685333B1 (fr) 1991-12-10 1991-12-10 Nouveau peptide notamment pour la realisation de conjugues immunogenes anti-lhrh, vaccins les incorporant et ensemble de vaccination y relatif.

Publications (2)

Publication Number Publication Date
FR2685333A1 FR2685333A1 (fr) 1993-06-25
FR2685333B1 true FR2685333B1 (fr) 1995-03-03

Family

ID=9419866

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9115289A Expired - Lifetime FR2685333B1 (fr) 1991-03-01 1991-12-10 Nouveau peptide notamment pour la realisation de conjugues immunogenes anti-lhrh, vaccins les incorporant et ensemble de vaccination y relatif.

Country Status (3)

Country Link
AU (1) AU640603B3 (fr)
FR (1) FR2685333B1 (fr)
MX (1) MX9207129A (fr)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1988005308A1 (fr) * 1987-01-14 1988-07-28 Commonwealth Scientific And Industrial Research Or Hormone contraceptive

Also Published As

Publication number Publication date
MX9207129A (es) 1994-06-30
AU640603B3 (en) 1993-08-26
FR2685333A1 (fr) 1993-06-25

Similar Documents

Publication Publication Date Title
IL90058A0 (en) Hiv envelope peptide,vaccines containing it,monoclonal antibodies directed against said peptide and pharmaceutical compositions containing said antibodies
IL98845A0 (en) Coconjugate vaccines comprising immunogenic protein,hiv related peptides,and anionic moieties,their preparation and pharmaceutical compositions containing them
IL190554A0 (en) Papilloma virus capsomere vaccine formulations and methods of use
ES2140076T3 (es) Vacunas que contienen una saponina y un esterol.
AU6979387A (en) Fusion protein comprising influenza virus haemagglutinin and antigenic epitope
CO5300414A1 (es) Composiciones de vacunas con antigenos de streptococus de virus vsr y adyuvante estimulador de respuesta th1
ES553425A0 (es) Perfeccionamientos en la fabricacion de conjugados de proteinas portadores de antigenos inmunogenicos para vacunas contra la malaria
AU3313789A (en) Haemophilus influenza type B oxidized polysaccharide-outer membrane protein conjugate vaccine
NZ239281A (en) Antigenic hiv conjugate, vaccine and pharmaceutical composition
Koplan et al. An update on the benefits and costs of measles and rubella immunization.
IL107387A (en) Combination pediatric vaccine with enhanced immunogenicity of each vaccine component
FR2685333B1 (fr) Nouveau peptide notamment pour la realisation de conjugues immunogenes anti-lhrh, vaccins les incorporant et ensemble de vaccination y relatif.
CA2133108A1 (fr) Vaccin a base de toxoide contre pasteurella haemolytica type a-1
HK1025220A1 (en) Novel saponin compositions and uses thereof
WO2002000250A3 (fr) Vaccins hiv-1 et methodes de depistage correspondantes
NZ223624A (en) Peptide immunogen from streptococcus mutans, vaccines and antibodies
FR2690839B1 (fr) Ensemble de vaccination contre l'interotoxemie du lapin et vaccin conditionne pour etre utilise dans cet ensemble.
EP0320034A3 (fr) Peptides synthétiques immunologiquement actifs utilisables pour préparer un vaccin contre le paludisme
FR2698271B1 (fr) Vaccin contre le virus de la leucémie bovine, nouveau peptide immunogène et kit de vaccination.
ZA915626B (en) Coconjugate vaccines comprising immunogenic protein,hiv related peptides,and anionic moieties
Makela A study of the antigenicity and immunogenicity of the measles virus surface proteins
GB9423663D0 (en) Viral preparations, immunogens, and vaccines
AU3751093A (en) Recombinant antigen containing in its sequence a heterologous immunostimulatory domain-use as a vaccine
Zourbas et al. Immunization of dental surgeons against hepatitis B virus infection.
AU8762591A (en) Flavivirus envelope proteins with increased immunogenicity for use in immunization against virus infection

Legal Events

Date Code Title Description
CD Change of name or company name